The trading price of Pfizer Inc. (NYSE:PFE) closed higher on Friday, April 19, closing at $26.00, 2.40% higher than its previous close.
The company’s P/E ratio in the trailing 12-month period was 72.34, while its 5Y monthly beta was 0.57. In examining the 52-week price action we see that the stock hit a 52-week high of $40.56 and a 52-week low of $25.23. Over the past month, the stock has lost -6.14% in value.
Pfizer Inc., whose market valuation is $146.82 billion at the time of this writing, is expected to release its quarterly earnings report May 01, 2024. The dividend yield on the company stock is 6.35%, while its Forward Dividend ratio is 1.65. Investors’ optimism about the company’s current quarter earnings report is understandable.
A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Pfizer Inc. No upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest PFE has a 100% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.
A quick review shows that PFE’s price is currently -2.92% off the SMA20 and -4.20% off the SMA50. The RSI metric on the 14-day chart is currently showing 39.82, and weekly volatility stands at 1.60%. When measured over the past 30 days, the indicator reaches 1.62%. Pfizer Inc. (NYSE:PFE)’s beta value is currently sitting at 0.62, while the Average True Range indicator is currently displaying 0.48.
To see how Pfizer Inc. stock has been performing in comparison to its peers in the industry, here are the numbers: PFE stock’s performance was 2.40% in the latest trading, and -35.39% in the past year. Pfizer Inc. has a P/E ratio of 72.34.
An evaluation of the daily trading volume of Pfizer Inc. (NYSE:PFE) indicates that the 3-month average is 42.79 million.
Currently, records show that 5.65 billion of the company’s shares remain outstanding. The insiders hold 0.04% of outstanding shares, whereas institutions hold 70.07%. However, since the stock’s price has seen -9.69% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
